Human formin FHOD3-mediated actin elongation is required for sarcomere integrity in cardiomyocytes
eLife · 2025
DOI: 10.7554/elife.104048 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Dylan A Valencia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, United States. Hauptthemen laut MEDLINE: Sarcomeres, Myocytes, Cardiac, Formins, Actins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Contractility and cell motility depend on accurately controlled assembly of the actin cytoskeleton. Formins are a large group of actin assembly proteins that nucleate and elongate new actin filaments. Some formins may cap filaments while others sever or bundle filaments. The formin homology domain-containing protein (FHOD) family of formins is critical to the formation of the fundamental contractile unit in muscle, the sarcomere. Specifically, mammalian FHOD3L plays an essential role in cardiomyocytes. Despite our knowledge of FHOD3L’s importance in cardiomyocytes, its biochemical and cellular activities remain poorly understood. It was proposed that FHOD-family formins act by capping and bundling, as opposed to assembling new filaments. Here, we demonstrate that human FHOD3L nucleates actin and rapidly but briefly elongates filaments after temporarily pausing elongation. We designed function-separating mutants that enabled us to distinguish which biochemical roles are required in the cell. We found that FHOD3L’s elongation activity, but not its nucleation, capping, or bundling activity, is necessary for proper sarcomere formation and contractile function in neonatal rat ventricular myocytes. The results of this work provide new insight into the mechanisms by which formins build specific structures and will contribute to knowledge regarding how cardiomyopathies arise from defects in sarcomere formation and maintenance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, United States.
- Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.
- Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, United States.
- Department of Computational Medicine, University of California, Los Angeles, Los Angeles, United States.
- Department of Medicine, Divison of Pulmonary and Critical Care Medicine, Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States.
- Molecular Biology Institute, University of California, Los Angeles, Los Angeles, United States.
ORCID-Profile: Dylan A Valencia, Haruko Nakano, Aanand A Patel, Airi Harui, Atsushi Nakano, Margot E Quinlan
Förderung
- NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
- National Institutes of Health
Zitieren
APA
Valencia, D. A., Koeberlein, A. N., Nakano, H., Rudas, A., Patel, A. A., Harui, A., Spencer, C., Nakano, A., & Quinlan, M. E. (2025). Human formin FHOD3-mediated actin elongation is required for sarcomere integrity in cardiomyocytes. eLife. https://doi.org/10.7554/elife.104048
Vancouver
Valencia DA, Koeberlein AN, Nakano H, Rudas A, Patel AA, Harui A, et al. Human formin FHOD3-mediated actin elongation is required for sarcomere integrity in cardiomyocytes. eLife. 2025. doi:10.7554/elife.104048
BibTeX
@article{Valencia2025,
author = {Valencia, Dylan A and Koeberlein, Angela N and Nakano, Haruko and Rudas, Akos and Patel, Aanand A and Harui, Airi and Spencer, Cassandra and Nakano, Atsushi and Quinlan, Margot E},
title = {Human formin FHOD3-mediated actin elongation is required for sarcomere integrity in cardiomyocytes},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.104048}
}
EUVIMED